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ABSTRACT Cultured skin fibroblasts from normal indi-
viduals and from patients with Duchenne muscular dystrophy
spread equally rapidly when seeded on a glass substratum. Ex-
posure to the ionophore monensin substantially suppresses
normal and dystrophic fibroblast spreading in serum-free me-
dia for up to at least 100 min. Preincubation of normal fibro-
blasts with monensin causes a further reduction in cell spread-
ing. Dystrophic fibroblasts fail to spread as well as normal
cells after monensin preincubation. Such findings indicate that
there is a delay in the secretion of functional adhesive surface
proteins in monensin-preincubated normal fibroblasts and
that this lag period is significantly longer in dystrophic fibro-
blasts. These data are consistent with findings of altered adhe-
sive and secretory properties of fibroblasts from patients with
Duchenne muscular dystrophy.
27) and others (28) have found that DMD fibroblasts appear
to be less adhesive than normal cells, and this may be related
to altered cell surface properties in DMD (29). We have stud-
ied the spreading ability of normal and DMD fibroblasts un-
der conditions in which protein secretion is altered by expo-
sure to monensin and report here that there is no difference
in the rate or extent of radial spreading between normal and
DMD fibroblasts in serum-free media. However, although
monensin suppresses the spreading of normal and DMD cells
to a similar degree, we demonstrate that, after prolonged
monensin preincubation, DMD fibroblasts fail to spread as
efficiently as normal cells, especially when monensin is re-
moved from the seeding media. These results are considered
in relation to a possible defect in the secretory and adhesive
properties of cultured DMD fibroblasts.
Fibronectin is a pericellular multidomain glycoprotein that is
involved in the active spreading of adherent fibroblasts (for
review, see ref. 1). It is also a major component of the extra-
cellular matrix (2, 3) and, together with collagen, is secreted
from human fibroblasts via the Golgi complex-endoplasmic
reticulum-lysosome (GERL) system (4). We have recently
reported that, in the absence of serum, the monovalent iono-
phore monensin greatly reduces the ability of cultured hu-
man skin fibroblasts to spread on a glass substratum (5). This
is probably a result of reduced matrix protein secretion (6)
due to a monensin-induced blockade at, or near, the Golgi
complex in human fibroblasts (7, 8) and other cell types (9-
11). Furthermore, fibronectin that is secreted by long-term
monensin-treated fibroblasts is abnormally glycosylated
(12); this may also affect the biological properties of this gly-
coprotein in mediating cell spreading (5).
Matrix proteins, such as collagen (13, 14) and fibronectin
(15), are abundant in muscles of patients suffering from Du-
chenne muscular dystrophy (DMD), an X chromosome-
linked, progressive wasting disease of skeletal musculature
(16). These observations, together with findings that colla-
gen synthesis (17, 18) and secretion (19) are increased in cul-
tured DMD fibroblasts, have led to suggestions that the con-
nective tissue proliferation which is seen in DMD muscle
may be closely associated with the etiology of the disorder
(20, 21).
Although the nature of the primary defect in DMD is un-
known, many reports have suggested an abnormality of the
cell surface in the disorder (for review, see ref. 22). Cultured
human skin fibroblasts provide a convenient system for in-
vestigating this possibility, since any membrane-mediated
changes are unlikely to be a consequence of probable sec-
ondary degenerative events, as in the case of muscle cells in
vivo (23, 24). Nor could the presence of putative circulating
factors (25) account for any membrane abnormality. We (26,
MATERIALS AND METHODS
Cell Cultures. Skin biopsy samples were obtained from the
upper surface of the thigh from four boys (1-12 years old)
who were investigated for muscle weakness but subsequent-
ly diagnosed as having no neuromuscular disease and from
nine boys with DMD (Table 1) as described (30). Cultures
were established from explants in 35-mm Petri dishes in Ea-
gle's minimal essential medium supplemented with 10% fetal
calf serum, penicillin at 50 international units/ml, and strep-
tomycin at 50 ug/ml. When a sufficient number of cells had
grown out from the explants, these cells were dissociated
with 0.25% trypsin in Ca2+/Mg2+-free Hanks' basal salts so-
lution (CMF) and transferred to 25-cm2 plastic culture
flasks. When these cultures were confluent, the cells were
treated with trypsin once more and transferred to 80-cm2
flasks. Cells were then subcultured weekly with 1:2 splits in
minimal essential medium supplemented with 10% newborn
calf serum and buffered with 10 mM Hepes. All media and
plastics were purchased from GIBCO Europe.
Cell Spreading. All cultures used (Table 1) were between
passages 8 and 20 and were grown to near confluence. Cul-
tures were washed in CMF and incubated for 20 min at room
temperature in 0.25% trypsin in CMF. Cells were then col-
lected, washed in CMF, and resuspended at a final concen-
tration of 2 x 105 cells per ml in serum-free minimal essential
medium at 4°C, as described (5). In most cases (see Table 1),
cell suspensions were divided into two aliquots which con-
tained either 0.5 ,uM ethanolic monensin (from Calbiochem-
Behring) or 0.1% ethanol alone (monensin control). Cells
were allowed to attach and spread at 37°C onto clean glass
multitest slides (Flow Laboratories) for 10, 30, 60, and 100
min. All cells were seeded within 30 min of dissociation.
Spreading was stopped by washing the slides briefly in 0.1 M
sodium cacodylate buffer, pH 7.2, and fixing for 30 min at
Abbreviations: DMD, Duchenne muscular dystrophy; GERL, Golgi
complex-endoplasmic reticulum-lysosome.
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Table 1. Identities of cultures used at each time point
Normal Dystrophic
10 30 60 100 10 30 60 100
Spreading medium min min min min min min min min
No monensin preincubation
Minimal essential medium JM/1 JM/1 JM/2 JM/2 CR/1 CR/1 CR/1 CR/1 AV/1
JM/2 JM/2 AP/1 JM/3 DS/1 DS/1 DS/1 DS/1 NS/1
AP/1 AP/2 AP/1 SA/1 SA/1 SA/1 SA/1 BP/1
AP/2 AP/2 BP/1 BP/1 MS/1 BP/2
SB/2 AP/3 MS/1 MS/1 RS/1 BP/3
Minimal essential medium/monensin SB/1 SB/1 SB/1 SB/1 CR/1 CR/1 CR/1 CR/1
JM/2 JM/2 JM/1 JM/1 DS/1 DS/1 DS/1 DS/1
AP/1 JM/2 JM/2 SA/1 SA/1 SA/1 SA/1
AP/2 AP/1 AP/1 BP/1 BP/1 BP/1
AP/2 AP/2 MS/1 MS/1 MS/1
Monensin preincubation*
Minimal essential medium and JM/4 JM/4 JM/4 JM/4 AP/3 CR/2 CR/2 CR/2 CR/2 DS/2
minimal essential medium/monensin SB/2 SB/2 SB/2 SB/2 DS/2 DS/2 DS/2 CR/3
AP/3 AP/3 AP/3 SB/3 SA/2 SA/2 SA/2 AC/1
SB/4 ND/1
VB/1 SA/2
Initials followed by a different number refer to a replicate culture. Initials followed by the same number indicate that cells from the same
culture flask were used.
*Twenty hours with 0.5 AM monensin.
room temperature in 2.5% (wt/vol) glutaraldehyde in caco-
dylate buffer.
The effect of monensin preincubation and recovery was
investigated by using normal and DMD fibroblast cultures
that had been established as described above. These cul-
tures, with a developed fibronectin matrix, were incubated
in minimal essential medium supplemented with 10% new-
born calf serum with 0.5 ,uM monensin for 20 hr at 37°C prior
to the final trypsin treatment. Incubating cultures with 0.1%
ethanol for 20 hr before dissociation had no effect on the
attachment or spreading of normal or DMD cells, as judged
by using the parameters described below. Preincubated cul-
tures were washed in CMF at 4°C, treated with trypsin, and
prepared for spreading as before. Prior to seeding of the
cells, suspensions were again divided into two aliquots; ei-
ther monensin was reintroduced (monensin block main-
tained) or ethanol was added (monensin block released).
Cell Area Measurements. Cells were examined by using
differential interference contrast microscopy on a Leitz
Orthoplan microscope. From each slide, 50 cells were photo-
graphed that fell on, or near, orthogonal diameters drawn
randomly across the visual field of the microscope. Mea-
surements of cell area were made from prints at a final mag-
nification of x 1340 by using a MOP-1 digitizer (Kontron,
Slough, U.K.) interfaced to a Commodore microcomputer
(27).
In a population of spreading cells, the measured cell areas
fit a negative binomial and not a Gaussian distribution (5),
thus cell area frequency distributions were compared by us-
ing the Kolmogorov-Smimov two-sample test (31), which
we have found suitable for this type of analysis (5). Cell ar-
eas were also logarithmically transformed to allow a para-
metric test of significance (Student's t test) to be performed
(Table 2). These tests were conducted on the means of
ln(area) and were obtained from the individual cultures listed
in Table 1. For cells allowed to spread for 100 min, signifi-
cance tests were additionally performed on the basis of indi-
vidual subjects (Table 3). In cases where replicate cultures
from the same subject were employed, the grand mean of
ln(area) for the subject was used.
As a measure of the uniformity of radial spreading in the
seeded fibroblasts, a form factor was calculated for all cells
measured. The form factor is a measure of the circularity of
an object and was adapted for this study as a parameter to
exclude cells that were either irregularly spread or had
ceased radial spreading and had become polarized. The form
factor is given by 4irA/P2, in which A and P are the object
area and perimeter, respectively. Thus a perfect circle has a
form factor of 1.0 and, in practice, cells with a form factor
>0.60 can be regarded as unspread or showing radial spread-
ing. All cells measured in this study were found to have a
form factor >0.55.
RESULTS
Cell Spreading in the Presence or Absence of Monensin.
Within 10 min of seeding, -90%o of normal and DMD fibro-
blasts were attached. No morphological differences could be
detected between the two genotypes. However, after 30 min,
most cells in both groups had started to spread as indicated
by the higher values for transformed means (Fig. 1A) of
these cells and the skewness of area frequency distributions
(data not shown).
Uniform radial spreading continued up to 100 min (Fig.
1A; Table 2) and by this stage nearly all normal and DMD
cells have spread with a well-established skirt of cytoplasm
extended around them (Fig. 2 A and B). At stages later than
100 min, the area of many normal and DMD cells was less
than the values found at 60 or 100 min. This decrease in cell
area is concomitant with the change in morphology from ra-
dial to polarized cells.
The addition of monensin to the seeding media did not ap-
pear to affect the attachment of normal or DMD cells. Simi-
larly, initial cell morphology and mean cell area (Table 2)
were unaffected by monensin treatment. By 30 min, howev-
er, spreading of monensin-treated cells appeared to be inhib-
ited, although it did not reach significance. At later stages
there is little further spreading of treated cells, and the differ-
ence from untreated cells is significant at both 60 min (P <
0.02) and 100 min (P < 0.01). Furthermore, the skirt of the
cytoplasm was ragged in profile (Fig. 2 C and D) compared
with the more regular outline of untreated cells (Fig. 2 A and
B). The difference in area distribution between treated and
untreated cells was greatest at 100 min. This can be seen by
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FIG. 1. Distribution of mean cell areas (Mum2) after natural-loga-
rithmic transformations. Values are shown for normal (0) and DMD
(0) cells seeded in the absence (A) or presence (B) of monensin. The
effect of 20-hr monensin preincubation is shown in C and D: monen-
sin-preincubated cells seeded in the absence (C) or presence (D) of
monensin. The arrows in C indicate the cultures used for the distri-
butions shown in Fig. 3.
the hack-transformed data of Table 2 and by the distribution
bf the (transformed) means (Fig. 1).
From 10 to 100 min after seeding, no differences were de-
tected between normal and DMD cells in response to monen-
sin treatment by either morphological appearance or analysis
of cell area distributions. It is important to note here that all
of these experiments (and those described below) were con-
ducted in serum-free media. When serum was present during
cell spreading (see Discussion) monensin failed to suppress
this process in DMD cells, as we have already shown for
normal skin fibroblasts (5).
Effect of Preincubation with Monensin. The effect of pro-
longed exposure to monensin, and any recovery from this
sustained blockade to secretion, was investigated by using
cells that had been preincubated with the ionophore for 20 hr
prior to trypsin treatment. This extended exposure to mon-
ensin did not affect cell size (Table 2), morphology, or at-
tachment in either normal or DMD fibroblasts, and it was
not initially affected by the addition or omission of monensin
in the seeding medium. However, within 30 min, many nor-
mal cells in which monensin was removed from the medium
had spread to a greater extent than those in which monensin
was maintained. The greater inhibition of normal cell spread-
ing (if monensin is reintroduced to the seeding medium) was
maintained for at least 100 min (Fig. iD, Tables 2 and 3).
Spreading in these cells was more reduced than in any of the
other experiments on normal cells described here (Table 4).
Normal cells from which monensin was removed continued
to spread (although to a limited extent), and by 100 min (Fig.
1C) they had spread to a similar extent (P > 0.05) as those
normal or DMD cells that were exposed to monensin only at
the time of seeding 'Fig. 1B). The majority of the former cells
had a well-defined rim of cytoplasm spread around them,
but, as in the short-term monensin-treated cells, the cell pe-
rimeter lacked the smoother profile of normal and DMD un-
treated cells (Fig. 2E).
DMD cells responded to the challenge of prolonged mon-
ensin preincubation and recovery in a manner different from
that of normal cells, and this was noticeable within 30 min of
seeding (Fig. iD). The removal of monensin had no signifi-
cant effect on the spreading ability ofDMD cells; even after
100 min, spreading of these cells was as inhibited as spread-
ing of those cells in which monensin was reintroduced (Fig.
1C; Tables 2 and 3). Both groups of DMD cells had spread
less than the equivalent normal cells by 100 min, but the
greatest difference was between normal and DMD monen-
sin-released cells at this time point (Figs. 1C and 2 E and F).
This difference was found whether genotypes were com-
pared on the basis of individual cultures (Table 2) or subjects
(Table 3). The latter classification was used to test whether
an unfairly weighted contribution was being made to the data
by, e.g., a single spurious subject from which replicate cul-
tures were analyzed.
Table 2. Area analysis of untreated qnd monensin-treated normal (N) and DMD cells
Area, ,Um2
10 min 30 min 60 min 100 min
Spreading medium N DMD N DMD N DMD N DMD
No monensin preincubation
Minimal essential medium MCA 184 194 380 480 682 775 973 1085
CL 51-657 140-268 239-605 373-619 444 1050 633-948 594-1591 929-1266
Minimal essential medium/monensin MCA 178 183 315 398 391 462 391 491
CL 63-502 121-276 193-516 303-524 281-543 300-713 200-766 290-833
Monensin preincubation*
Minimal essential medium MCA 195 173 265 184t 273 195 413 198t
CL 169-224 119-251 164-427 146-232 179-417 111-342 296-577 183-215
Minimal essential medium/monensin MCA 183 171 209 171 249 174 307 183t
CL 139-240 152-191 132-331 140-209 142-434 134-225 245-385 165-203
All values represent back-transformed data, thus the MCA values are not the observed mean cell areas. These data are generated from the
values shown in Fig. 1. MCA, mean cell area; CL, 95% confidence limits. Since the transformation was nonlinear, these are asymmetric about
the mean.
*Twenty hours with 0.5 ,AM monensin.tSignificantly different from normal at P < 0.02, by Student's t test.
tSignificantly different from normal at P < 0.001, by Student's t test.
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Table 4. Summary of cell spreading in control and monensin-
treated skin fibroblasts
Spreading
Spreading medium Normal DMD
No monensin preincubation
Minimal essential medium ++++ ++++
Minimal essential medium/
monensin +++ +++
Monensin preincubation*
Minimal essential medium +++ +
Minimal essential medium/
monensin + + 0/t
Spreading ability is represented by estimates of increasing cell
area on an arbitrary scale from 0 to + + + +. All values represent the
extent of spreading 100 min after cell seeding.
*Twenty hours with 0.5 AuM monensin.
FIG. 2. Normal (A, C, and E) and DMD (B, D, and F) fibroblasts
allowed to attach and spread for 100 min on glass substrata. (A and
B) Untreated cells. (C and D) Cells seeded in the presence of 0.5 A.M
monensin. (E and F) Cells preincubated with monensin for 20 hr and
then allowed to spread in monensin-free medium. All micrographs
are shown for illustration only; measurements were made from
prints at much greater magnification. (Bars = 20 Am.)
Most (>60%) of the DMD cells were completely unspread
by 100 min, and the remainder often exhibited only short
filopodia which contributed very little to any increase in cell
Table 3. Mean cell area analysis of 100-min samples on the basis
of subjects
Area, AMm2
Spreading medium Normal DMD P*
No monensin preincubation
Minimal essential medium 911 1034 NS
Minimal essential medium/
monensin 354 491 NS
Monensin preincubation
Minimal essential medium 453 200 <0.001t
Minimal essential medium/
monensin 309t 186 <0.001t
All values represent back-transformed data. Number of subjects
is given in Table 1.
*Probability values derived from Student's t test. NS, not signifi-
cant.
tIt should be noted that these differences could be due to a gene
independent of DMD. In this case, the probability of four normal
and five DMD subjects forming two, discrete distributions is given
by 1:28-i.e., P < 0.004.
tSignificantly different from monensin-preincubated normal cells
seeded in minimal essential medium alone (P < 0.02).
area. Cell area frequency distributions of normal and DMD
monensin-released cells show the inhibition of spreading in
the latter by the much-reduced right-hand tail of'the graph
(Fig. 3). Analysis of the pooled values for normal and DMD
monensin-released cells by the Kolmogorov-Smirnov two-
sample test also shows a significant (P < 0.01) difference
between these two populations. This behavior of normal and
DMD cells was seen consistently in six normal and six DMD
cultures (Fig. 1C).
DISCUSSION
In this report we have demonstrated that DMD cells settle
onto glass substrata and spread to the same extent as normal
cells and, further, that the spreading process is equally inhib-
ited in both genotypes by monensin added at the time of plat-
ing. Uchida et al. (6) have demonstrated that 7-hr exposure
to 50 nM monensin can reduce fibronectin and collagen se-
cretion in human fibroblasts by -60%. Exposure to monen-
sin (6, 32) produces a delay of up to 6 hr after incubation in
monensin-free medium before secretion approaches control
values. Under the conditions we have used, the efficiency of
monensin appears to be sufficient to reduce glycoprotein se-
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FIG. 3. Representative cell area frequency distributions of nor-
mal (o) and DMD (e) cells seeded for 100 min in monensin-free me-
dium after 20-hr monensin preincubation. The transformed means of
these distributions are shown arrowed in Fig. 1. The distributions of
normal (AP/3) and DMD (CR/3) are those closest to the grand
means for either genotype and are shown for illustration of true cell
size. However, such relative inhibition of spreading in DMD cells
under these conditions was seen in all cultures examined.
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cretion below the threshold level (33) required for successful
spreading: this applies to both normal and DMD fibroblasts.
It should be mentioned that monensin-induced spreading
inhibition is masked by the presence of serum in the seeding
medium (5). Since serum-derived fibronectin is known to be
incorporated into cell layers (34) and substrata (35), it seems
probable that both increased cell spreading in serum-supple-
mented media and the failure of monensin to suppress cell
spreading under these conditions are due to the provision of
sufficient serum-derived elements-e.g., fibronectin-to
support rapid cell spreading.
Although short-term exposure to monensin has similar ef-
fects on normal and DMD cell spreading, preincubation with
monensin for 20 hr causes a much more pronounced reduc-
tion in DMD cells, even when the drug is removed before
seeding. In particular, it is most noticeable in such cells that
have been allowed to spread in monensin-free medium for
100 min. This observation may be correlated with the re-
newed secretion of biologically active fibronectin after re-
lease from long-term monensin exposure (12). This is con-
sistent with a series of studies (32, 36-38) confirming that the
transit time for newly synthesized fibronectin to reach the
cell surface is -30 min. The inability ofDMD cells to recov-
er spreading ability to the same extent as normal cells may
thus be a consequence of a greater delay in the reconstitution
of the GERL secretory pathway compared with normal fi-
broblasts. The pleiotropic action of monensin could distin-
guish between normal and DMD cells in other ways [for ex-
ample, ionic substitution in model and cell membranes (39)
and microtubule organization (40)], but this does not seem
probable. However, our observations on seeding efficiency
after prolonged exposure to the ionophore suggest no dam-
age to the biochemical mechanisms required for cell-sub-
strate attachment. Cell morphology, trypan blue exclusion,
and the partial recovery of normal monensin-released cells
within 30-100 min all demonstrate that long-term monensin
exposure per se is neither lethal nor irreversibly disabling to
the complex biochemical and ultrastructural systems re-
quired for cell-substrate spreading.
Finally, a defect in the recovery of cell spreading in DMD
monensin-released fibroblasts may be correlated with previ-
ous reports of abnormal cell-cell adhesiveness (26, 27) and
cell-substratum detachment (28) in DMD fibroblasts. Kent
(28) has demonstrated that the detachment rate of DMD fi-
broblasts from plastic substrata by trypsin was greater than
that of normal cells and also that DMD fibroblasts were
more sensitive to lower concentrations of trypsin. We have
found (unpublished data) that the reduction in intercellular
adhesiveness ofDMD cells is lost when the cells are given a
2-hr recovery period after trypsin treatment. This recovery
period, prior to aggregation, allows for the replacement of
surface material damaged or removed by trypsin (41). Such
observations, taken with those of Kent (28), suggest that the
failure of DMD cells to recover normally from a monensin
blockade may be related to the adhesive surface properties
ofDMD cells and to the replacement of surface or secretory
adhesive proteins. The 30-min transit time [in the case of
fibronectin (36)] involves the de novo synthesis of the glyco-
protein, post-translational modification, and transport
through the GERL system. A defect in such secretion-relat-
ed mechanisms could account for abnormal DMD cell adhe-
siveness (26, 27), the behavior of DMD cells in their re-
sponse to monensin, and previous reports (17-19, 29) of ab-
normalities in the synthesis of GERL-associated proteins in
DMD.
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